ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2310건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1561 | Recruiting | DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia | Pneumonia, Viral | Drug: Dexamethasone | Phase 3 | Hospital Universitario Infanta Leonor, Fundacion para la Investigacion e Innovacion Biomedica del Hospital Universitario Infanta Leonor, Kern Pharma, S.L. | OTHER | 126 | All | 18 Years | Hospital Universitario Infanta Leonor, Madrid, Spain Hospital Universitario Clinico San Carlos, Madrid, Spain Hospital Emergencias Enfermera Isabel Zendal, Madrid, Spain |
| 1560 | Terminated | Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial | Covid-19 | Drug: High-Dose Dexamethasone | Phase 3 | Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno | OTHER | 100 | All | 18 Years | Hospital Universitario Sede Saaveda - IUC CEMIC, Caba, Argentina Hospital Universitario Sede Pombo - IUC CEMIC, Ciudad Autonoma de Buenos Aires, Argentina Sanatorio Sagrado Corazon, Ciudad Autonoma de Buenos Aires, Argentina Clinica Bazterrica, Ciudad Autonoma de Buenos Aires, Argentina |
| 1559 | Terminated | Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 | COVID-19 | Drug: Dexamethasone and Hydroxychloroquine Drug: Hydroxychloroquine |
Phase 3 | Centre Chirurgical Marie Lannelongue | OTHER | 5 | All | 18 Years ~ 80 Years | Reanimation adulte. Hopital Marie Lannelongue, Le Plessis-Robinson, France |
| 1558 | Unknown status | Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 | ARDS | Drug: Dexamethasone Drug: Methylprednisolone |
Phase 3 | Chattogram General Hospital, Health Science Center of Xi'an Jiaotong University | OTHER_GOV | 60 | All | 20 Years ~ 80 Years | Chattogram General Hospital, Chittagong, Bangladesh M. Abdur Rahim Medical College Hospital, Dinajpur, Bangladesh |
| 1557 | Completed | Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19 | Covid19 | Drug: Linagliptin tablet Drug: Insulin |
Phase 3 | Hospital Regional de Alta Especialidad del Bajio | OTHER | 70 | All | 18 Years ~ 75 Years | Hospital Regional de Alta Especialidad del Bajio, Leon, Guanajuato, Mexico |
| 1556 | Completed | DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1) | COVID-19 Infection | Drug: rhDNase I | Phase 1 | McGill University Health Centre/Research Institute of the McGill University Health Centre, Hamilton Health Sciences Corporation, Hoffmann-La Roche, Exactis Innovation | OTHER | 15 | All | 18 Years | Hamilton General Hospital, Hamilton Health Sciences, Hamilton, Ontario, Canada McGill University Health Centre, Montreal, Quebec, Canada |
| 1555 | Terminated | DISulfiram for COvid-19 (DISCO) Trial | Covid19 | Drug: Disulfiram Drug: Placebo |
Phase 2 | University of California, San Francisco | OTHER | 11 | All | 18 Years | University of California San Francisco, Fresno, Fresno, California, United States San Francisco General Hospital, San Francisco, California, United States |
